Safety of solanezumab in the expedition-ext study up to 2 years in a mild to moderate Alzheimer’s disease population
Carlson, Christopher D., Sethuraman, Gopalan, Andersen, Scott W., Holdridge, Karen C., Hoog, Sharon L., Hayduk, Roza, Siemers, Eric R.Volume:
11
Language:
english
Journal:
Alzheimer's & Dementia
DOI:
10.1016/j.jalz.2015.06.1658
Date:
July, 2015
File:
PDF, 44 KB
english, 2015